Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 1)
Carcinoma, Merkel Cell (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 1)
Colorectal Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 1)
Esophageal Neoplasms (Phase 1)
Glioblastoma (Early Phase 1)
Head and Neck Neoplasms (Phase 1)
Healthy Volunteers (Phase 1)
Laryngeal Neoplasms (Phase 1)
Lung Neoplasms (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Melanoma (Phase 2)
Mouth Neoplasms (Phase 1)
Multiple Myeloma (Phase 1)
Mutation (Phase 1)
Neoplasms (Phase 1)
Oropharyngeal Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Pharyngeal Neoplasms (Phase 1)
Prostatic Neoplasms, Castration-Resistant (Phase 1/Phase 2)
Rectal Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue